39743-22-1Relevant articles and documents
triAZOLOtriAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS
-
Page/Page column 59-59, (2020/01/24)
The present invention provides triazolotriazine derivatives of formula (1) as A2A receptor antagonists. Compounds of formula (1) and pharmaceutical compositions including the compounds can be used for the treatment of disorders related to A2A receptor hyperfunctioning, such as certain types cancers. Compounds of formula (1) and methods of preparing the compounds are disclosed in the invention.
Thiazolyl-Benzimidazoles
-
Page/Page column 28, (2010/07/04)
The invention is directed to compounds of formula (1) and pharmaceutically acceptable salts thereof, methods for the preparation thereof, and methods of use thereof.